First Time Loading...

Avanos Medical Inc
NYSE:AVNS

Watchlist Manager
Avanos Medical Inc Logo
Avanos Medical Inc
NYSE:AVNS
Watchlist
Price: 19.58 USD 0.56%
Updated: May 13, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.7B
-2%
Assets
Growth Rates:
1 Year
-5%
3 Years
+1%
5 Years
-8%
7 Years
-18%
10 Years
-32%
456.1m
-9%
Liabilities
Growth Rates:
1 Year
-8%
3 Years
+10%
5 Years
-15%
7 Years
-53%
10 Years
+13%
1.2B
+1%
Equity
Growth Rates:
1 Year
-4%
3 Years
-2%
5 Years
-5%
7 Years
+12%
10 Years
-41%

Balance Sheet Decomposition
Avanos Medical Inc

1.7B
Assets
456.1m
Liabilities
1.7B
Assets
456.1m
Liabilities
Current Assets 487m
Cash & Short-Term Investments 87.7m
Receivables 142.8m
Other Current Assets 256.5m
Non-Current Assets 1.2B
PP&E 144m
Intangibles 1B
Other Non-Current Assets 25.8m
Current Liabilities 234.6m
Accounts Payable 56.3m
Accrued Liabilities 106m
Other Current Liabilities 72.3m
Non-Current Liabilities 221.5m
Long-Term Debt 159.4m
Other Non-Current Liabilities 62.1m

Balance Sheet
Avanos Medical Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
149
130
114
220
385
205
112
119
128
88
Cash Equivalents
149
130
114
220
385
205
112
119
128
88
Total Receivables
234
225
190
203
151
164
168
131
168
143
Accounts Receivables
234
225
190
203
151
164
109
118
156
129
Other Receivables
0
0
0
0
0
0
59
13
12
14
Inventory
283
303
273
91
121
146
169
159
190
163
Other Current Assets
19
19
17
647
57
24
19
19
14
93
Total Current Assets
685
676
594
1 161
714
539
467
428
500
487
PP&E Net
278
280
261
110
154
249
224
207
195
144
PP&E Gross
278
280
261
110
154
249
224
207
195
144
Accumulated Depreciation
291
320
352
78
84
99
114
136
155
123
Intangible Assets
108
83
170
149
168
184
158
141
251
240
Goodwill
1 426
945
1 029
765
784
801
803
802
819
796
Other Long-Term Assets
31
17
19
12
14
27
22
27
22
26
Other Assets
1 426
945
1 029
765
784
801
803
802
819
796
Total Assets
2 528
N/A
2 000
-21%
2 072
+4%
2 196
+6%
1 833
-17%
1 800
-2%
1 673
-7%
1 604
-4%
1 787
+11%
1 692
-5%
Liabilities
Accounts Payable
169
163
173
171
170
83
68
56
68
56
Accrued Liabilities
176
152
151
145
94
130
99
83
112
106
Short-Term Debt
4
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
40
0
0
0
0
6
9
Other Current Liabilities
8
0
0
34
0
0
0
0
0
64
Total Current Liabilities
356
315
324
390
264
213
166
139
186
235
Long-Term Debt
632
578
579
541
248
248
180
130
226
159
Deferred Income Tax
28
24
36
18
4
0
6
12
25
24
Other Liabilities
20
28
30
32
20
74
64
52
58
38
Total Liabilities
1 036
N/A
945
-9%
969
+3%
981
+1%
536
-45%
534
0%
416
-22%
333
-20%
496
+49%
456
-8%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
7
419
379
300
242
288
316
304
253
315
Additional Paid In Capital
1 503
1 518
1 533
1 551
1 578
1 594
1 609
1 629
1 646
1 664
Unrealized Security Profit/Loss
0
0
49
0
34
32
28
34
36
27
Treasury Stock
0
1
2
4
5
9
10
21
67
86
Other Equity
19
43
1
31
1
1
0
0
0
0
Total Equity
1 491
N/A
1 055
-29%
1 103
+4%
1 215
+10%
1 297
+7%
1 265
-2%
1 257
-1%
1 271
+1%
1 291
+2%
1 236
-4%
Total Liabilities & Equity
2 528
N/A
2 000
-21%
2 072
+4%
2 196
+6%
1 833
-17%
1 800
-2%
1 673
-7%
1 604
-4%
1 787
+11%
1 692
-5%
Shares Outstanding
Common Shares Outstanding
47
47
47
47
47
48
48
48
47
46

See Also

Summary
AVNS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AVNS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AVNS stock valuation using valuation multiples.
Wall Street Estimates
AVNS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AVNS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.